Showing results (11-20 of 37) with videos related to
Sort By:
Pageof 4
In Vivo (Athens, Greece)|March 31, 2005
Clinical pharmacokinetics of imatinib mesylateDominique Levêque, Frédéric MaloiselJournal of Clinical Pharmacology|April 20, 2007
Molecular pharmacokinetics of catharanthus (vinca) alkaloidsDominique Levêque, François JehlBulletin Du Cancer|May 17, 2023
Oral anticancer agents as generators of relevant pharmacokinetic interactionsCamelia Machkouri, Dominique LevêqueExpert Opinion on Drug Safety|September 4, 2019
The role of therapeutic drug monitoring in the management of safety of anticancer agents: a focus on 3 cytotoxicsDominique Levêque, Guillaume BeckerAnticancer Research|August 6, 2005
Pharmacokinetics of therapeutic monoclonal antibodies used in oncologyDominique Levêque, Sandra Wisniewski, François JehlBritish Journal of Clinical Pharmacology|May 7, 2011
Cola beverage and delayed elimination of methotrexateRaoul Santucci, Dominique Levêque, Raoul HerbrechtCurrent Clinical Pharmacology|August 12, 2008
Clinical pharmacology of trastuzumabDominique Levêque, Luc Gigou, Jean Pierre BergeratInternational Journal of Antimicrobial Agents|March 28, 2006
Clinical pharmacokinetics of voriconazoleDominique Levêque, Yasmine Nivoix, François Jehl, et al.In Vivo (Athens, Greece)|April 18, 2007
Review. Clinical pharmacokinetics of bortezomibDominique Levêque, Marie Christine Monteiro Carvalho, Frederic MaloiselExpert Review of Clinical Pharmacology|November 25, 2011
Pharmacokinetic drug-drug interactions with methotrexate in oncologyDominique Levêque, Raoul Santucci, Bénédicte Gourieux, et al.Pageof 4